These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17892263)

  • 1. The ansacarbamitocins: polar ansamitocin derivatives.
    Snipes CE; Duebelbeis DO; Olson M; Hahn DR; Dent WH; Gilbert JR; Werk TL; Davis GE; Lee-Lu R; Graupner PR
    J Nat Prod; 2007 Oct; 70(10):1578-81. PubMed ID: 17892263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational biosynthesis of ansamitocin antibiotics: a diversity-oriented approach to exploit biosynthetic flexibility.
    Knobloch T; Harmrolfs K; Taft F; Thomaszewski B; Sasse F; Kirschning A
    Chembiochem; 2011 Mar; 12(4):540-7. PubMed ID: 22238146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new antitumour ansamitocin from Actinosynnema pretiosum.
    Wei GZ; Bai LQ; Yang T; Ma J; Zeng Y; Shen YM; Zhao PJ
    Nat Prod Res; 2010 Jul; 24(12):1146-50. PubMed ID: 20582809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amide N-glycosylation by Asm25, an N-glycosyltransferase of ansamitocins.
    Zhao P; Bai L; Ma J; Zeng Y; Li L; Zhang Y; Lu C; Dai H; Wu Z; Li Y; Wu X; Chen G; Hao X; Shen Y; Deng Z; Floss HG
    Chem Biol; 2008 Aug; 15(8):863-74. PubMed ID: 18721757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoenzymatic approaches toward dechloroansamitocin P-3.
    Meyer A; Brünjes M; Taft F; Frenzel T; Sasse F; Kirschning A
    Org Lett; 2007 Apr; 9(8):1489-92. PubMed ID: 17378571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioreduction of aryl azides during mutasynthesis of new ansamitocins.
    Mancuso L; Jürjens G; Hermane J; Harmrolfs K; Eichner S; Fohrer J; Collisi W; Sasse F; Kirschning A
    Org Lett; 2013 Sep; 15(17):4442-5. PubMed ID: 23981134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitubulin activities of ansamitocins and maytansinoids.
    Ikeyama S; Takeuchi M
    Biochem Pharmacol; 1981 Sep; 30(17):2421-5. PubMed ID: 21043240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel ansamitocin analogs from Actinosynnema pretiosum.
    Siyu-Mao ; Hong-Chen ; Li-Chen ; Chuanxi-Wang ; Wei-Jia ; Xiaoming-Chen ; Huangjian-Yang ; Wei-Huang ; Wei-Zheng
    Nat Prod Res; 2013; 27(17):1532-6. PubMed ID: 23061718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly active ansamitocin derivatives: mutasynthesis using an AHBA-blocked mutant.
    Taft F; Brünjes M; Floss HG; Czempinski N; Grond S; Sasse F; Kirschning A
    Chembiochem; 2008 May; 9(7):1057-60. PubMed ID: 18381586
    [No Abstract]   [Full Text] [Related]  

  • 10. The interplay between mutasynthesis and semisynthesis: generation and evaluation of an ansamitocin library.
    Eichner S; Knobloch T; Floss HG; Fohrer J; Harmrolfs K; Hermane J; Schulz A; Sasse F; Spiteller P; Taft F; Kirschning A
    Angew Chem Int Ed Engl; 2012 Jan; 51(3):752-7. PubMed ID: 22135226
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of the cryptic stereochemistry of the first PKS chain-extension step in ansamitocin biosynthesis by Actinosynnema pretiosum.
    Kubota T; Brünjes M; Frenzel T; Xu J; Kirschning A; Floss HG
    Chembiochem; 2006 Aug; 7(8):1221-5. PubMed ID: 16927319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined muta- and semisynthesis: a powerful synthetic hybrid approach to access target specific antitumor agents based on ansamitocin P3.
    Taft F; Harmrolfs K; Nickeleit I; Heutling A; Kiene M; Malek N; Sasse F; Kirschning A
    Chemistry; 2012 Jan; 18(3):880-6. PubMed ID: 22170289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of thermocleavable conjugates based on ansamitocin and superparamagnetic nanostructured particles by a chemobiosynthetic approach.
    Mancuso L; Knobloch T; Buchholz J; Hartwig J; Möller L; Seidel K; Collisi W; Sasse F; Kirschning A
    Chemistry; 2014 Dec; 20(52):17541-51. PubMed ID: 25346489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An isolable acyclic hemiacetal of ansamitocin P-3.
    Segraves NL; Yazzie D; Deese AJ
    Magn Reson Chem; 2012 Mar; 50(3):256-9. PubMed ID: 22374862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual carbamoylations on the polyketide and glycosyl moiety by asm21 result in extended ansamitocin biosynthesis.
    Li Y; Zhao P; Kang Q; Ma J; Bai L; Deng Z
    Chem Biol; 2011 Dec; 18(12):1571-80. PubMed ID: 22195559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the bacterial community in the root system of the maytansine containing plant Putterlickia verrucosa.
    Wings S; Müller H; Berg G; Lamshöft M; Leistner E
    Phytochemistry; 2013 Jul; 91():158-64. PubMed ID: 22795602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methylation of the amide bond by methyltransferase asm10 in ansamitocin biosynthesis.
    Wu Y; Kang Q; Shang G; Spiteller P; Carroll B; Yu TW; Su W; Bai L; Floss HG
    Chembiochem; 2011 Jul; 12(11):1759-66. PubMed ID: 21681880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ansamitocin P-3, a maytansinoid, from Claopodium crispifolium and Anomodon attenuatus or associated actinomycetes.
    Suwanborirux K; Chang CJ; Spjut RW; Cassady JM
    Experientia; 1990 Jan; 46(1):117-20. PubMed ID: 2298279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclization of synthetic seco-proansamitocins to ansamitocin macrolactams by Actinosynnema pretiosum as biocatalyst.
    Harmrolfs K; Brünjes M; Dräger G; Floss HG; Sasse F; Taft F; Kirschning A
    Chembiochem; 2010 Dec; 11(18):2517-20. PubMed ID: 21077088
    [No Abstract]   [Full Text] [Related]  

  • 20. Ansamitocins, maytansinoid antitumor antibiotics. Producing organism, fermentation, and antimicrobial activities.
    Tanida S; Hasegawa T; Hatano K; Higashide E; Yoneda M
    J Antibiot (Tokyo); 1980 Feb; 33(2):192-8. PubMed ID: 7380728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.